Aspartate glutamate carrier (citrin) deficiency

  • Keiko Kobayashi
  • Takeyori Saheki

Abstract

The mitochondrial inner membrane harbors a set of carrier proteins for metabolite transport that constitute a superfamily of related proteins (Krämer and Palmieri 1992; Walker 1992; Palmieri 1994; Palmieri and van Ommen 1999). Many metabolite transporters or carriers with the feature s of the mitochondrial carrier family are now classified as solute carrier family 25 (SLC25). The members of SLC25 are each composed of approximately 300 amino acid s comprising three homologous domains repeated in tandem, each about 100 amino acids long, that contain a conserved sequence motif, each with two hydrophobic α-helical segments connected by an extensive hydrophilic sequence and two putative mitochondrial transmembrane (TM) spanners (Krämer and Palmieri 1992; Walker 1992; Palmieri 1994). A topological model predicts six TM spanners with amino and carboxyl termini on the cytosolic side and hydrophilic loops on the matrix side.

Keywords

Schizophrenia Pancreatitis Arginine Adenine Triglyceride 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Begum, L., Jalil, M.A., Kobayashi, K., Iijirna, M., Li, M.X., Yasuda, T., Horiuchi, M., del Arco, A., Satrústegui, J., and Saheki, T. (2002). Expression of Three Mitochondrial Solute Carriers, Citrin, Aralar l, and Ornithine Transporter, in Relation to Urea Cycle in Mice. Biochim. Biophys. Acta., 1574, 283–292.PubMedCrossRefGoogle Scholar
  2. Ben-Shalom, E., Kobayashi, K., Shaag, A., Yasuda, T, Gao, HZ., Saheki, T, Bachmann, C., and Elpeleg, O. (2002). Infantile Citrullinemia caused by Citrin Deficiency with Increased Dibasic Amino Acids. Mol. Genet. Metab., 77, 202–208.PubMedCrossRefGoogle Scholar
  3. Chow, W.C., Ng, H.S., Tan, L.K., and Thum, T.Y (1996). Case Report: Recurrent Hyperammonaemic Encephalopathy due to Citrullinaemia in a 52 Year Old Man. J. Gastroenterol. Hepatol., 11, 621–625.PubMedCrossRefGoogle Scholar
  4. Crackower, M.A., Sinasac, D.S., Lee, J.R., Herbrick, J.A., Tsui, L.C., and Scherer, S.W. (1999). Assignment of the SLC25A 12 Gene Coding for the Human Calcium-Binding Mitochondrial Solute Carrie r Protein Aralar to Human Chromosome 2q24. Cytogenet. Cell. Genet., 87, 197–198.PubMedCrossRefGoogle Scholar
  5. del Arco, A., Agudo, M., and Satrústegui, J. (2000). Characterization of a Second Member of the Subfamily of Calcium-Binding Mitochondrial Carriers Expressed in Human Non-Excitable Tissues. Biochem. J., 345, 725–732.PubMedCrossRefGoogle Scholar
  6. del Arco, A., Morcillo, J., Martinez-Morales, J.R., Galián, C, Martos, V., Bovolenta, P., and Satrústegui, J. (2002). Expression of the Aspartate-Glutamate Mitochondrial Carriers Aralar l and Citrin during Development and Adult Rat Tissues. Eur. J. Biochem., 269, 3313–3320.PubMedCrossRefGoogle Scholar
  7. del Arco, A., and Satrústegui, J. (1998). Molecular Cloning of Aralar, a New Member of the Mitochondrial Carrier Superfamily that Binds Calcium and is Present in Human Muscle and Brain. J. Bioi. Chem., 273, 23327–23334.CrossRefGoogle Scholar
  8. Hwu, W.L., Kobayashi, K., Hu, Y.H., Yamaguchi, N., Saheki, T, Chou, S.P., and Wang, J.H. (2001). A Chinese Adult-Onset Type II Citrullinaemia Patient with 851del4/1638 ins23 Mutations in the SLC25A13 Gene. J. Med. Genet., 38, E23.PubMedCrossRefGoogle Scholar
  9. Iijima, M., Jalil, M.A., Begum, L., Yasuda, T, Yamaguchi, N., Li, M.X., Kawada, N., Endou, H., Kobayashi, K., and Saheki, T (2001). Pathogene sis of Adult-Onset Type II Citrullinemia caused by deficiency of Citrin, a Mitochondrial Solute Carrier Protein: Tissue and Subcellular Localization of Citrin. Adv. Enzyme. Regul., 41, 325–342.PubMedCrossRefGoogle Scholar
  10. Ikeda, S., Yazaki, M., Takei, Y., Ikegami, T., Hashikura, Y., Kawasaki, S., Iwai, M., Kobayashi, K., and Saheki, T. (2002). Type II (Adult-Onset) Citrullinaemia: Clinical Pictures and the Therapeutic Effect of Liver Transplantation. J. Neurol. Neurosurg. Psychiatry, 71, 663–670.CrossRefGoogle Scholar
  11. Imamura, Y., Kobayashi, K., Shibatou, T., Aburada, S., Tahara, K., Kubozono, O., and Saheki, T (2003). Effectiveness of Carbohydrate-Restricted Diet and Arginine Granules Therapy for Adult-Onset Type II Citrullinemia: A Case Report of Siblings Showing Homozygous SLC25A13 Mutation with and without the Disease. Hepatology Res. 26, 68–72.CrossRefGoogle Scholar
  12. Kasahara, M., Ohwada, S., Takeichi, T, Kaneko, H., Tomomasa, T., Morikawa, A., Yonernura, K., Asonuma, K., Tanaka, K., Kobayashi, K., Saheki, T., Takeyoshi I., and Morishita, Y. (2001). Living-Related Liver Transplantation for Type II Citrullinemia using a Graft from Heterozygote Donor. Transplantation, 70, 157–159.CrossRefGoogle Scholar
  13. Kawamoto, S., Strong, R.W., Kerlin, P., Lynch, S.V., Steadman, C., Kobayashi, K., Nakagawa, S., Matsunami, H., Akatsu, T., and Saheki, T. (1997). Orthotopic Liver Transplantation for Adult-Onset Type II Citrullinaemia. Clin. Transplantation, 11, 453–458.Google Scholar
  14. Kobayashi, K., Horiuchi, M., and Saheki, T. (1997). Pancreatic Secretory Trypsin Inhibitor as a Diagnostic Marker for Adult-Onset Type II Citrullinemia. Hepatology, 25, 1160–1165.PubMedCrossRefGoogle Scholar
  15. Kobayashi, K., Iijima, M., Yasuda, T., Sinasac, D.S., Yamaguchi, N., Tsui, R. C., Scherer, S.W., and Saheki, T. (2000). Type II Citrullinemia (Citrin Deficiency): A Mysterious Disease Caused by a Defect of Calcium-Binding Mitochondrial Carrier Protein. Calcium: The Molecular Basis of Calcium Action in Biology and Medicine. Dordrecht: Kluwer. pp. 565–587.Google Scholar
  16. Kobayashi, K., Kakinoki, H., Fukushige, T., Shaheen, N., Terazono, H., and Saheki, T. (1995a). Nature and Frequency of Mutations in the Argininosuccinate Synthetase Gene that cause Classical Citrullinemia. Hum. Genet., 96, 45–63.CrossRefGoogle Scholar
  17. Kobayashi, K., Nakata, M., Terazono, H., Shinsato, T., and Saheki, T. (1995b). Pancreatic Secretory Trypsin Inhibitor Gene is Highly Expressed in the Liver of Adult-Onset Type II Citrullinemia. FEBS Lett., 372, 69–73.PubMedCrossRefGoogle Scholar
  18. Kobayashi, K., Saheki, T., Imamura, Y., Noda, T., Inoue, I., Matuo, S., Hagihara, S., Norniyama, H., Jinno, Y., and Shimada, K. (1986). Messenger RNA Coding for Argininosuccinate Synthetase in Citrullinemia. Am. J. Hum. Genet., 38, 667–680.PubMedGoogle Scholar
  19. Kobayashi, K., Shaheen, N., Kurnashiro, R., Tanikawa, K., O’Brien, W.E., Beaudet, A.L., and Saheki, T. (1993). A Search for the Primary Abnormality in Adult-Onset Type II Citrullinemia. Am. J. Hum. Genet., 53, 1024–1030.PubMedGoogle Scholar
  20. Kobayashi, K., Shaheen, N., Terazono, H., and Saheki, T. (1994). Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia. Am. J. Hum. Genet., 55, 1103–1112.PubMedGoogle Scholar
  21. Kobayashi, K., Sinasac, D.S., Iijima, M., Boright, A.P., Begum, L., Lee, J.R., Yasuda, T., Ikeda, S., Hirano, R., Terazono, H., Crackower, M.A., Kondo, I., Tsui, L.C., Scherer, S.W., and Saheki, T. (1999). The Gene Mutated in Adult-Onset Type II Citrullinaemia Encodes a Putative Mitochondrial Carrier Protein. Nat. Genet., 22, 159–163.PubMedCrossRefGoogle Scholar
  22. Kramer, R. and Palmieri, E. (1992). Metabolite Carriers in Mitochondria. Molecular Mechanisms in Bioenergetics. Amsterdam: Elsevier Science Publishers, pp. 359–384.Google Scholar
  23. Lee, J., Ellaway, C., Kobayashi, K., and Wilcken, B. (2002). Citrullinaemia type II: A Rare Cause of Neonatal Hepatitis detected by Newborn Screening. J. Inherit. Metab. Dis. 25(suppl. I), 29.Google Scholar
  24. Maruyama, H., Ogawa, M., Nishio, T., Kobayashi, K., Saheki, T., and Sunohara, N. (2001). Citrullinemia Type II in a 64-Year-Old Man with Fluctuating Serum Citrulline Levels. J. Neurol. Sci., 182, 167–170.PubMedCrossRefGoogle Scholar
  25. Nagata, N., Matsuda, I., and Oyanagi, K. (1991). Estimated Frequency of Urea Cycle Enzymopathies in Japan. Am. J. Med. Genet., 39, 228–229.PubMedCrossRefGoogle Scholar
  26. Naito, E., Ito, M., Matsuura, S., Yokota, I., Saijo, T., Ogawa, Y., Kitamura, S., Kobayashi, K., Saheki, T., Nishimura, Y., Sakura, N., and Kuroda, Y. (2002). Type II Citrullinemia (Citrin Deficiency) in a Neonate with Hypergalactosaemia Detected by Mass Screening. J. Inherit. Metab. Dis., 25, 71–76.PubMedCrossRefGoogle Scholar
  27. Ohura, T., Kobayashi, K., Tazawa, Y., Nishi, I., Abukawa, D., Sakamoto, O., Iinurna, K., and Saheki, T. (2001). Neonatal Presentation of Adult-Onset Type II Citrullinemia. Hum. Genet., 108, 87–90.PubMedCrossRefGoogle Scholar
  28. Onuki, J., Nishimura, S., Yoshino, K., Takahashi, H., Suzuki, T., Abe, K., Sakurabayashi, S., Iwase, T., Hirano, M., Kobayashi, K., and Saheki, T. (2000). Genetic Abnormality in 2 Brothers of a Case With Adult-Onset Type II Citrullinemia: Trial of Pre-Onset Genetic Diagnosis. Acta. Hepatologica. Jpn. (Japanese), 41, 555–560.CrossRefGoogle Scholar
  29. Oshiro, S., Kochinda, T., Tana, T., Yamazato, M., Kobayashi, K., Kornine, Y., Muratani, H., Saheki, T., Iseki, K., and Takishita, S. (2002). A Patient with Adult-Onset Type I Citrullinemia on Long-Term Hemodialysis: Reversal of Clinical Symptoms and Brain MRI Findings. Am. J. Kidney Dis., 39, 189–192.PubMedCrossRefGoogle Scholar
  30. Palmieri, E., (1994). Mitochondrial Carrier Proteins. FEBS. Lett., 346, 48–54.PubMedCrossRefGoogle Scholar
  31. Palmieri, E. and van Ommen, B. (1999). The Mitochondrial Carrier Protein Family. Frontiers of Cellular Bio energetics. New York: Kluwer Academic/Plenum Publishers. pp. 489–519.Google Scholar
  32. Palmieri, L., Pardo, B., Lasorsa, F.M., del Arco, A., Kobayashi, K., lijima, M., Runswick, M.J., Walker, J.E., Saheki, T., Satnistegui, J., and Palmieri, E. (2001). Citrin and Aralarlare Ca2+-Stimulated Aspartatel Glutamate Transporters in Mitochondria. EMBO. J., 20, 5060–5069.PubMedCrossRefGoogle Scholar
  33. Ross, B.D., Hems, R., and Krebs, H.A. (1967). The Rat of Gluconeogenesis from Various Precursors in the Perfused Rat Liver. Biochem. J., 102, 942–951.PubMedGoogle Scholar
  34. Saheki, T. and Kobayashi, K. (2002) Mitochondrial Aspartate Glutamate Carrier (Citrin) Deficiency as the Cause of Adult-Onset Type II Citrullinemia (CTLN2) and Idiopathic Neonatal Hepatitis (NICCD). J. Hum. Genet., 47, 333–341.PubMedCrossRefGoogle Scholar
  35. Saheki, T., Kobayashi, K., and Inoue, I. (1987a). Hereditary Disorders of the Urea Cycle in Man: Biochemical and Molecular Approaches. Rev. Physiol. Biochem. Pharmacol., 108, 21–68.PubMedCrossRefGoogle Scholar
  36. Saheki, T., Kobayashi, K., Inoue, I., Matuo, S., Hagihara, S., and Noda, T. (1987b). Increased Urinary Excretion of Argininosuccinate in Type II Citrullinemia. Clin. Chim. Acta., 170, 297–304.PubMedCrossRefGoogle Scholar
  37. Saheki, T., Kobayashi, K., Miura, T., Hashimoto, S., Ueno, Y., Yamasaki, T., Araki, H., Nara, H., Shiozaki, Y., Sarneshima, Y., Suzuki, M., Yamauchi, Y., Sakazume, Y., Akiyama, K., and Yamamura, Y. (1986 ). Serum Amino Acid Pattern of Type II Citrullinemic Patients and Effect of Oral Administration of Citrulline. J. Clin. Biochem. Nutr., 1, 129–142.CrossRefGoogle Scholar
  38. Saheki, T., Nakano, K., Kobayashi, K., Imamura, Y., Itakura, Y., Sase, M., Hagihara, S., and Matuo, S. (1985). Analysis of the Enzyme Abnormality in Eight Cases of Neonatal and Infantile Citrullinemia in Japan. J. Inherit. Metab. Dis., 8, 155–156.PubMedCrossRefGoogle Scholar
  39. Saheki, T., Sase, M., Nakano, K., Azuma, E., and Katsunuma, T. (1983a). Some Properties of Argini-nosuccinate Synthetase Purified from Human Liver and a Comparison with the Rat Liver Enzyme. J. Biochem., 93, 1531–1537.PubMedGoogle Scholar
  40. Saheki, T., Ueda, A., Hosoya, M., Kusumi, K., Takada, S., Tsuda, M., and Katsunuma, T. (1981). Qualitative and Quantitative Abnormalities of Argininosuccinate Synthetase in Citrullinemia. Clin. Chim. Acta., 109, 325–335.PubMedCrossRefGoogle Scholar
  41. Saheki, T., Ueda, A., Iizima, K., Yamada, N., Kobayashi, K., Takahashi, K., and Katsunuma, T. (1982). Argininosuccinate Synthetase Activity in Cultured Skin Fibroblasts of Citrullinemic Patients. Clin. Chim. Acta., 118, 93–97.PubMedCrossRefGoogle Scholar
  42. Saheki, T., Yagi, Y., Sase, M., Nakano, K., and Sato, E. (1983b). Immunohistochemical Localization of Argininosuccinate Synthetase in the Liver of Control and Citrullinemic Patients. Biomed. Res., 4, 235–238.Google Scholar
  43. Sase, M., Kobayashi, K., Imamura, Y., Saheki, T., Nakano, K., Miura, S., and Mori, M. (1985). Level of Translatable Messenger RNA Coding for Argininosuccinate Synthetase in the Liver of the Patients with Quantitative-Type Citrullinemia. Hum. Genet., 69, 130–134.PubMedCrossRefGoogle Scholar
  44. Sinasac, D.S., Crackower, M.A., Lee, J.R., Kobayashi, K., Saheki, T., Scherer, S.W., and Tsui, L.C. (1999). Genomic Structure of the Adult-Onset Type II Citrullinemia Gene, SLC25A13, and Cloning and Expression of its Mouse Homologue. Genomics, 62, 289–292.PubMedCrossRefGoogle Scholar
  45. Takashima, Y., Koide, M., Fukunaga, H., Iwai, M., Miura, M., Yoneda, R., Fukuda, T., Kobayashi, K., and Saheki, T. (2002). Recovery from Marked Altered Consciousness in a Patient with Adult-Onset Type II Citrullinemia Diagnosed by DNA Analysis and Treated with a Living Related Partial Liver Transplantation. Internal Medicine, 41, 555–560.PubMedCrossRefGoogle Scholar
  46. Takenaka, K., Yasuda, I., Araki, H., Naito, T., Fukutomi, Y., Ohnishi, H., Yamakita, N., Hasegawa, T., Sato, H., Shimizu, Y., Matsunami, H., and Moriwaki, H. (2000). Type II Citrullinemia in an Elderly Patient Treated with Living Related Partial Liver Transplantation. Internal Medicine, 39, 553–558.PubMedCrossRefGoogle Scholar
  47. Tamamori, A., Okano, Y., Ozaki, H., Fujimoto, A., Kajiwara, M., Fukuda, K., Kobayashi, K., Saheki, T., Tagami Y., and Yamano, T. (2002). Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency: Severe Hepatic Dysfunction in an Infant Requiring Liver Transplantation. Eur. J. Pediatr., 161, 609–613.PubMedCrossRefGoogle Scholar
  48. Tazawa, Y., Kobayashi, K., Ohura, T., Abukawa, D., Nishinomiya, E., Hosoda, Y., Yamashita, M., Nagata, I., Kono, Y., Yasuda, T., Yamaguchi, N., and Saheki, T. (2001). Infantile Cholestatic Jaundice Associated With Adult-Onset Type II Citrullinemia. J. Pediatr., 138, 735–740.PubMedCrossRefGoogle Scholar
  49. Todo, S., Starzl, T.E., Tzakis, A., Benkov, K.J., Kalousek, E., Saheki, T., Tanikawa, K., and Fenton, W.A. (1992). Orthotopic Liver Transplantation for Urea Cycle Enzyme Deficiency. Hepatology, 15, 419–422.PubMedCrossRefGoogle Scholar
  50. Tomomasa, T., Kobayashi, K., Kaneko, H., Shimura, H., Fukusato, T., Tabata, M., Inoue, Y., Ohwada, S., Kasahara, M., Morishita, Y, Kimura, M., Saheki, T., and Morikawa, A. (2001). Possible Clinical and Histologic Manifestations of Adult-Onset Type II Citrullinemia in Early Infancy. J. Pediatr., 138, 741–743.PubMedCrossRefGoogle Scholar
  51. Tsuboi, Y., Fujino, Y., Kobayashi, K., Saheki, T., and Yamada, T. (2001). High Serum Pancreatic Secretory Trypsin Inhibitor Before Onset of Type II Citrullinemia. Neurology, 57, 933.PubMedCrossRefGoogle Scholar
  52. Tsujii, T., Morita, T., Matsuyama, Y., Matsui, T., Tamura, M., and Matsuoka, Y. (1976). Sibling Cases of Chronic Recurrent Hepatocerebral Disease with Hypercitrullinemia. Gastroenterologia. Jpn., 11, 328–340.Google Scholar
  53. Walker, J.E. (1992). The Mitochondrial Transporter Family. Curr. Opin. Struct. Biol., 2, 519–526.CrossRefGoogle Scholar
  54. Yagi, Y., Saheki, T., Imamura, Y., Kobayashi, K., Sase, M., Nakano, K., Matuo, S., Inoue, I., Hagihara, S., and Noda, T. (1988). The Heterogeneous Distribution of Argininosuccinate Synthetase in the Liver of Type II Citrullinemic Patients: Its Specificity and Possible Clinical Implications. Am. J. Clin. Pathol., 89, 735–741.PubMedGoogle Scholar
  55. Yajima, Y., Hirasawa, T., and Saheki, T. (1981). Treatment of Adult-Type Citrullinemia with Administration of Citrate. Tohoku. J. Med., 134, 321–330.CrossRefGoogle Scholar
  56. Yamaguchi, N., Kobayashi, K., Yasuda, T., Nishi, I., Iijima, M., Nakagawa, M., Osame, M., Kondo, I., and Saheki, T (2002). Screening of SLC25A13 Mutations in Early and Late Onset Patients with Citrin Deficiency and in the Japanese Population: Identification of Two Novel Mutations and Establishment of Multiple DNA Diagnosis Methods for Nine Mutations. Hum. Mutat., 19, 122–130.PubMedCrossRefGoogle Scholar
  57. Yasuda, T., Yamaguchi, N., Kobayashi, K., Nishi, I., Horinouchi, H., Jalil, M.A., Li, M.X., Ushikai, M., Iijima, M., Kondo, I., and Saheki, T. (2000). Identification of Two Novel Mutations in the SLC25A13 Gene and Detection of Seven Mutations in 102 Patients with Adult-Onset Type II Citrullinemia. Hum. Genet., 107, 537–545.PubMedCrossRefGoogle Scholar
  58. Yazaki, M., Ikeda, S., Takei, Y., Yanagisawa, N., Matsunami, H., Hashikura, Y, Kawasaki, S., Makuuchi, M., Kobayashi, K., and Saheki, T. (1996). Complete Neurological Recovery of an Adult Patient With Type II Citrullinaemia after Living Related Partial Liver Transplantation. Transplantation, 62, 1679–1681.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Keiko Kobayashi
    • 1
  • Takeyori Saheki
    • 1
  1. 1.Department of Molecular Metabolism and Biochemical GeneticsKagoshima University Graduate School of Medical and Dental SciencesKagoshimaJapan

Personalised recommendations